Uniqure Nv Stock Price on February 2, 2025

QURE Stock  USD 12.23  0.28  2.24%   
Below is the normalized historical share price chart for Uniqure NV extending back to February 05, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Uniqure NV stands at 12.23, as last reported on the 9th of March, with the highest price reaching 12.77 and the lowest price hitting 12.09 during the day.
IPO Date
20th of June 2007
200 Day MA
8.6673
50 Day MA
14.6454
Beta
0.363
 
Yuan Drop
 
Covid
If you're considering investing in Uniqure Stock, it is important to understand the factors that can impact its price. Uniqure NV is risky given 3 months investment horizon. Uniqure NV owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.1, which indicates the firm had a 0.1 % return per unit of risk over the last 3 months. We were able to interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.57% are justified by taking the suggested risk. Use Uniqure NV Risk Adjusted Performance of 0.1063, coefficient of variation of 817.76, and Semi Deviation of 5.06 to evaluate company specific risk that cannot be diversified away.
  
At present, Uniqure NV's Stock Based Compensation To Revenue is projected to increase slightly based on the last few years of reporting. . The current year's Price Earnings To Growth Ratio is expected to grow to 0.16, whereas Price To Sales Ratio is forecasted to decline to 30.10. Uniqure Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1046

Best PortfolioBest Equity
Good Returns
Average ReturnsQURE
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 15.01
  actual daily
96
96% of assets are less volatile

Expected Return

 1.57
  actual daily
31
69% of assets have higher returns

Risk-Adjusted Return

 0.1
  actual daily
8
92% of assets perform better
Based on monthly moving average Uniqure NV is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Uniqure NV by adding it to a well-diversified portfolio.
Price Book
2.8334
Enterprise Value Ebitda
0.9891
Price Sales
24.3873
Shares Float
44.4 M
Wall Street Target Price
36.1775

Related Headline

Rocket Pharmaceuticals Headline on 31st of January 2025

SG Americas Securities LLC Purchases 48,793 Shares of Rocket Pharmaceuticals, Inc.

Uniqure NV Valuation on February 2, 2025

It is possible to determine the worth of Uniqure NV on a given historical date. On February 2, 2025 Uniqure was worth 15.72 at the beginning of the trading date compared to the closed value of 15.74. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Uniqure NV stock. Still, in general, we apply an absolute valuation method to find Uniqure NV's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Uniqure NV where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Uniqure NV's related companies.
 Open High Low Close Volume
  15.48    16.01    15.11    15.79    958,867  
01/31/2025
  15.72    16.07    15.36    15.74    884,187  
  15.00    15.88    14.78    15.75    593,833  
Backtest Uniqure NV  |  Uniqure NV History  |  Uniqure NV Valuation PreviousNext  
Open Value
15.72
15.74
Closing Value
60.76
Upside

Uniqure NV Trading Date Momentum on February 2, 2025

On February 03 2025 Uniqure NV was traded for  15.75  at the closing time. The top price for the day was 15.88  and the lowest listed price was  14.78 . The trading volume for the day was 593.8 K. The trading history from February 3, 2025 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 0.06% . The trading price change against the current closing price is 7.31% .
JavaScript chart by amCharts 3.21.1501/31/2025Jan 21Jan 24Jan 27Jan 30FebFeb 05Feb 0814.014.515.015.516.0

Uniqure NV Fundamentals Correlations and Trends

By evaluating Uniqure NV's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Uniqure NV's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Uniqure financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Uniqure NV Stock history

Uniqure NV investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Uniqure is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Uniqure NV will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Uniqure NV stock prices may prove useful in developing a viable investing in Uniqure NV
Last ReportedProjected for Next Year
Common Stock Shares Outstanding48.6 M35.7 M
Net Loss-145.8 M-138.5 M

Uniqure NV Quarterly Net Working Capital

350.24 Million

Uniqure NV Stock Technical Analysis

Uniqure NV technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Uniqure NV technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Uniqure NV trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Uniqure NV Period Price Range

Low
March 9, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

Uniqure NV cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Uniqure NV March 9, 2025 Market Strength

Market strength indicators help investors to evaluate how Uniqure NV stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Uniqure NV shares will generate the highest return on investment. By undertsting and applying Uniqure NV stock market strength indicators, traders can identify Uniqure NV entry and exit signals to maximize returns

Uniqure NV Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Uniqure NV's price direction in advance. Along with the technical and fundamental analysis of Uniqure Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Uniqure to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Uniqure Stock analysis

When running Uniqure NV's price analysis, check to measure Uniqure NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Uniqure NV is operating at the current time. Most of Uniqure NV's value examination focuses on studying past and present price action to predict the probability of Uniqure NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Uniqure NV's price. Additionally, you may evaluate how the addition of Uniqure NV to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm

Trending Assets

RNA
Avidity Biosciences
30.29  -0.06  -0.2 
PTGX
Protagonist Therapeutics
38.35  -0.7  -1.79 
TERN
Terns Pharmaceuticals
3.49  -0.14  -3.86 
STRO
Sutro Biopharma
1.50  0.03  2.04 
MGTX
MeiraGTx Holdings PLC
6.38  -0.08  -1.24 
PHAT
Phathom Pharmaceuticals
5.06  -0.84  -14.24 
AMLX
Amylyx Pharmaceuticals
3.87  0.26  7.20 
XFOR
X4 Pharmaceuticals
0.35  -0.03  -7.89 
RCKT
Rocket Pharmaceuticals
8.77  -0.22  -2.45 
RYTM
Rhythm Pharmaceuticals
50.79  -0.85  -1.65 
PCVX
Vaxcyte
71.18  -3.63  -4.85 
GPCR
Structure Therapeutics
22.62  -0.91  -3.87 
KRTX
Karuna Therapeutics
0.00  0.00  0.00 
REPL
Replimune Group
11.51  -0.23  -1.96 
SLDB
Solid Biosciences LLC
5.42  -0.08  -1.45 
MRUS
Merus BV
46.07  -0.03  -0.07 
INZY
Inozyme Pharma
1.15  -0.08  -6.5 
SNDX
Syndax Pharmaceuticals
13.42  -0.87  -6.09 
LRMR
Larimar Therapeutics
3.03  -0.03  -0.98 
KNSA
Kiniksa Pharmaceuticals
21.51  0.24  1.13